Finance entity
markets is the sole category represented across all 1 tracked stories. Candel Therapeutics is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 6 runs below the beat's 6.3 for that window.
Last mentioned: Feb 20, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets is the sole category represented across all 1 tracked stories. Candel Therapeutics is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 6 runs below the beat's 6.3 for that window. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. We currently track 1 Finance story that mention Copart, all published on February 20, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 75 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Copart. Shared-story counts are live from our verified record — not editorial picks.
Candel Public Offering
Candel Therapeutics prices $100M public offering at $5.45 per share.
Trial Data Release
Grail shares slide as NHS-Galleri trial misses primary endpoint for late-stage cancer reduction.
GDP Release
U.S. government scheduled to release Q4 GDP growth figures at 8:30 AM ET.
Grail Earnings
Grail reports Q4 and Full Year 2025 financial results, beating revenue and EPS estimates.
US equity futures signaled a positive open on Friday as investors shifted focus toward the release of fourth-quarter GDP figures. Following a lackluster Thursday session, the market is looking for confirmation of economic resilience while monitoring individual movers like Grail and Candel Therapeutics.
Source: Benzinga · benzinga.com
Copart is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
